Pilot Trial of "Chemo-Switch" Regimen to Treat Advanced Melanoma
Status:
Terminated
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This research study is testing the "chemo-switch" strategy in melanoma, using biochemotherapy
initially to shrink tumors and then switching to daily low-dose chemotherapy (temozolomide)
together with sorafenib. The purpose of this study is to find out what effects (good and bad)
biochemotherapy followed by temozolomide plus sorafenib have on melanoma.